Sam Brusco, Associate Editor10.26.22
Medtronic announced the launch of its Medtronic Neurovascular Co-Lab platform to accelerate innovation in stoke care and treatment.
The Neurovascular Co-Lab platform is an always-on virtual portal for neurovascular innovator submissions, which are then assessed and prioritized to choose a path forward. Chose opportunities will be progressed based on their individual needs, including exposing innovators to Medtronic's network of experts, thought leaders and partners for collaboration, clinical study funding, and strategic and directional guidance.
"We need to act now to prioritize the best concepts and strongest products to ensure they reach more patients sooner," Dan Volz, president of Medtronic’s Neurovascular business told the press. "Clinicians and innovators are passionate about improving stroke care, and the neurovascular technology market is brimming with ideas, improvements, and would-be therapies in need of development. Our platform will provide both an infrastructure and a process to realize viable opportunities on a previously unmatched scale."
According to the company, the Neurovascular Co-Lab Platform will help bring neurovascular innovations to life. The process will be both transparent and collaborative, ensuring opportunities advance effectively and responsibly.
"What's fascinating about the neurovascular field is that we still have so much to discover about the brain. Medtronic has always invested in innovative stroke treatment technologies leading the standard of care and advancing the practice of neurosurgery," said Brett Wall, executive vice president and president of the Medtronic Neuroscience Portfolio. "The neurovascular market has enormous growth potential, and we invite innovative start-ups, physicians, venture-capital firms and inventors to collaborate with us as we set out to change stroke care as we know it today. With more than 90,000 employees across 150 countries—combined with our proven record in stroke innovation—Medtronic is positioned well to help address this urgent challenge."
The platform will be launched on October 29, World Stroke Day.
The Neurovascular Co-Lab platform is an always-on virtual portal for neurovascular innovator submissions, which are then assessed and prioritized to choose a path forward. Chose opportunities will be progressed based on their individual needs, including exposing innovators to Medtronic's network of experts, thought leaders and partners for collaboration, clinical study funding, and strategic and directional guidance.
"We need to act now to prioritize the best concepts and strongest products to ensure they reach more patients sooner," Dan Volz, president of Medtronic’s Neurovascular business told the press. "Clinicians and innovators are passionate about improving stroke care, and the neurovascular technology market is brimming with ideas, improvements, and would-be therapies in need of development. Our platform will provide both an infrastructure and a process to realize viable opportunities on a previously unmatched scale."
According to the company, the Neurovascular Co-Lab Platform will help bring neurovascular innovations to life. The process will be both transparent and collaborative, ensuring opportunities advance effectively and responsibly.
"What's fascinating about the neurovascular field is that we still have so much to discover about the brain. Medtronic has always invested in innovative stroke treatment technologies leading the standard of care and advancing the practice of neurosurgery," said Brett Wall, executive vice president and president of the Medtronic Neuroscience Portfolio. "The neurovascular market has enormous growth potential, and we invite innovative start-ups, physicians, venture-capital firms and inventors to collaborate with us as we set out to change stroke care as we know it today. With more than 90,000 employees across 150 countries—combined with our proven record in stroke innovation—Medtronic is positioned well to help address this urgent challenge."
The platform will be launched on October 29, World Stroke Day.